The Evidence Supporting Sales Rep Access Restrictions To Physicians – “Where’s The Beef?”

White paper

The Evidence Supporting Sales Rep Access Restrictions To Physicians – “Where’s The Beef?”

The last 10-15 years have seen an explosion of articles in major health policy and medical journals advocating severely restricting or banning biopharmaceutical sales rep access to ...

Biosimilars In The US - Will They Deliver On The Promise?

Blog

Biosimilars In The US – Will They Deliver On The Promise?

Research presented from Mylan Pharmaceuticals at the recently held 2016 annual meeting of the American Society of Clinical Oncology (ASCO) generated excitement within the medical c ...

Challenges To Traditional Pharma Incentive Compensation Plan Design

White paper

Challenges To Traditional Pharma Incentive Compensation Plan Design

Changes in emerging environmental trends facing the pharma industry are requiring companies to rethink different strategic and operational sales force plans that ultimately drive n ...

The Pricing Challenge Of Pharma's Shift To Specialty Medicines

White paper

The Pricing Challenge Of Pharma’s Shift To Specialty Medicines

The shift to specialty medicines has opened up for pharma companies a wealth of opportunities in addressing unmet medical needs of patients and improve the cost of care. This shift ...

White paper

Measuring Sales Rep-Physician Relationship Disruption In Sales Force Optimization

There is a growing importance of maintaining sales rep-physician relationships and accounting for their disruption in sales force optimization and territory alignment analyses. Thi ...

White paper

Driver Score – The New Paradigm

Of late, telematics as a disruptive technology is rapidly gaining attention in shaping the future. New industries are accepting this revolution and are moving to data-backed decisi ...

White paper

At Supplier Management Crossroads? – Choose The Right Approach

Of late, regulators have started focusing attention on the way banks and financial institutions are managing the risk in their supplier management programs. ...

White paper

Deploying K-Nearest Neighbor Modeling Methodologies For Real World Problems

There has been an immense improvement of theory and algorithms in recent times leading to enhancement in computation power. Also, online data availability was never easier than now ...

White paper

A Mathematical Framework For Privacy Risk

In recent trends, people’s attitude towards the internet has changed tremendously. The willingness and comfort level of people to share and reveal information about themselves an ...

White paper

Operational Risk Management In Banks

In recent years, more than 100 losses exceeding US$ 100 million have been reported, prompting the regulators to turn their focus towards effectiveness of Operational Risk Managemen ...

White paper

Basel Downturn – Identification & Estimation

As part of Basel accords, banks and other financial institution should hold sufficient capital to buffer against large unexpected losses. Minimum capital required, for pillar 1, is ...

White paper

Borrower Centrism- Bring ‘Service’ Back Into Mortgage Servicing

Mortgage Servicers are entrusted with almost all vital operations, ranging from payment collection to loss mitigation attempts. However, until January 2014, no strict regulations w ...

No more posts to display!

White paper

Borrower Centrism- Bring ‘Service’ Back Into Mortgage Servicing

Mortgage Servicers are entrusted with almost all vital operations, ranging from payment collection to loss mitigation attempts. However, until January 2014, no strict regulations w ...

White paper

Behavioural Segment Based Stress Testing Using Markov Chain

Stress testing involves assessing a bank’s ability to stay solvent in case of ‘stressed’ macro-economic scenarios. Banks are expected to create a response mechanism in case a ...

White paper

Evolution Of SDLC

Today, more than ever before, success or failure of a banking enterprise abides a direct correlation towards its ability to meet the demanding time to market conditions. ...

White paper

Portfolio Stress Testing Methodologies

As the world is crawling out of the global economic crisis, several efforts are underway by regulators as well as international organizations, such as the International Monetary Fu ...

White paper

Claim Operations Optimization

Processing claims quickly and accurately is one of the biggest challenges payers face today. Huge volume of claims notwithstanding, multiple and incompatible systems requiring sign ...

White paper

Enabling Smarter Commercial Model Experimentation

The pharmaceutical industry is changing and manufacturers need to modify approaches and structures to survive in a competitive environment. ...

White paper

Linking Customer Focus With Business Performance

The concept of the ‘customer-centric business’ is pervasive, with companies small and large, across every industry, making efforts to improve customer focus. ...

White paper

Risk Basel Methodology Implementation

Basel will have significant impact on the banking sector. One recent study1 estimated that as the Basel rules are written today; by 2019 the US banks will need about $870 billion o ...

White paper

Is Channel ROI Dead?

From broadcasting a series of monologues at ‘easy’ customers in order to sell products, to having an engaging and effective dialogue with fairly ‘complex’ targets to make m ...

White paper

Operational Risk Computation Methodology

Operational Risk has become a key area of priority for the banks in the recent past due to regulatory pressures. The banks are identifying ways of measuring, monitoring, and predic ...

White paper

Mortgage Servicer – You’ve Got Information!

In the wake of the crisis, the mortgage industry has been under pressure to reform the way loans are underwritten and serviced. In particular, there is significant regulatory press ...

White paper

Payer Influence On Product Performance In Pharmaceutical Industry

Payers vary in their ability to assert formulary compliance. We will explore how tools and analytics can enable a pharmaceutical manufacturer to assess factors impacting formulary ...

Let us help your business today.
Contact us now to start your journey.